Changing Malaria Treatment Policy in Zambia
Author Information
Author(s): Sipilanyambe Naawa, Simon Jonathon L, Chanda Pascalina, Olumese Peter, Snow Robert W, Hamer Davidson H
Primary Institution: Department of Community Medicine, University of Zambia
Hypothesis
How can Zambia effectively transition from chloroquine to artemether-lumefantrine for malaria treatment?
Conclusion
The Zambian experience shows that successful drug policy changes require strong political commitment and a harmonized national consensus among stakeholders.
Supporting Evidence
- Malaria cases in Zambia nearly tripled from 1976 to 1999.
- The decision to change to artemether-lumefantrine was made in 2002.
- Implementation began with a phased approach starting in 2003.
Takeaway
Zambia changed its malaria treatment from an old drug to a new one to help sick people get better faster. This change needed a lot of teamwork and money to work well.
Methodology
The study reviewed all published and unpublished evidence related to the antimalarial drug policy change and included authors' observations.
Potential Biases
Potential bias from authors' involvement in the policy change process.
Limitations
The study may not capture all local variations in implementation and challenges faced in different districts.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website